Patents by Inventor Yaing Rong

Yaing Rong has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nitrogen heterocycle biaryls for osteoporosis and other diseases
    Patent number: 7365209
    Abstract: Nitrogen heterocycle biaryls having a carboxylate terminus are useful for treating endometriosis, osteoporosis, restenosis following angioplasty, rheumatoid arthritis, cancer, macular degeneration and obesity. Compounds of formula: are disclosed.
    Type: Grant
    Filed: February 10, 2004
    Date of Patent: April 29, 2008
    Assignee: Pharmacopeia, Inc.
    Inventors: Jeffrey John Letourneau, Vidyahar Paradkar, Michael H. J. Ohlmeyer, Lawrence W. Dillard, John J. Baldwin, Christopher Mark Riviello, Angela Wong, Yaing Rong
  • NITROGEN HETEROCYCLE BIARYLS FOR OSTEOPOROSIS AND OTHER DISEASES
    Publication number: 20080051423
    Abstract: Nitrogen heterocycle biaryls having a carboxylate terminus are useful for treating endometriosis, osteoporosis, restenosis following angioplasty, rheumatoid arthritis, cancer, macular degeneration and obesity. Compounds of formula: are disclosed.
    Type: Application
    Filed: August 23, 2007
    Publication date: February 28, 2008
    Applicant: PHARMACOPEIA, INC.
    Inventors: Jeffrey Letourneau, Vidyahar Paradkar, Michael Ohlmeyer, Lawrence Dillard, John Baldwin, Christopher Riviello, Angela Wong, Yaing Rong
  • Nitrogen heterocycle biaryls for osteoporosis and other diseases
    Publication number: 20050222203
    Abstract: Nitrogen heterocycle biaryls having a carboxylate terminus are useful for treating endometriosis, osteoporosis, restenosis following angioplasty, rheumatoid arthritis, cancer, macular degeneration and obesity. Compounds of formula: are disclosed.
    Type: Application
    Filed: February 10, 2004
    Publication date: October 6, 2005
    Applicant: Pharmacopeia, Inc.
    Inventors: Jeffrey Letourneau, Vidyahar Paradkar, Michael Ohlmeyer, Lawrence Dillard, John Baldwin, Christopher Riviello, Angela Wong, Yaing Rong